先天代謝異常用医療食品の世界市場レポート 2025年

先天代謝異常用医療食品の市場規模は、今後数年で急成長が見込まれます。2029年にはCAGR11.8％で54億3,000万米ドルに成長します。予測期間の成長は、遠隔医療統合、クリーンラベル製品に対する需要の高まり、新生児スクリーニングプログラムの拡大、患者中心のケアモデル、植物由来の持続可能な製剤などに起因しています。予測期間における主な動向には、遺伝子検査の技術的進歩、食品加工技術の進歩、成分技術の革新、食品配合の技術的進歩などがあります。

遺伝子（遺伝性）障害の有病率の増加が、今後数年間における先天代謝異常用医療食品市場の成長を牽引すると予想されます。遺伝性疾患は、標準的なDNA配列の全体的または部分的な変異によって引き起こされる病態です。医療用食品は、代謝障害を持つ乳幼児に特殊な栄養を提供する上で重要な役割を果たし、その乳幼児特有の代謝ニーズを満たすように調整されるため、栄養不足を予防し、乳幼児の成長を支援するのに役立ちます。例えば、2024年5月、米国の公衆衛生機関である疾病対策予防センター（CDC）は、鎌状赤血球症（SCD）は米国で約10万人が罹患しており、罹患者の90％以上が非ヒスパニック系黒人またはアフリカ系アメリカ人であり、推定3％～9％がヒスパニック系またはラテン系であると報告しました。その結果、遺伝性疾患の増加が先天代謝異常用医療食品市場の成長に拍車をかけています。

高齢化人口の増加が、先天性代謝異常用医療食品市場の成長を今後数年間押し上げると予測されます。高齢化とは、社会における高齢者の割合の増加を特徴とする人口動態を指します。先天代謝異常用医療食品は、特定の障害を持つ高齢者が直面する栄養ニーズや代謝上の課題に対応するものです。例えば、2022年1月、米国を拠点とする連邦政府機関である議会予算局は、社会保障給与税と給付の対象となる人口が、2024年の3億4,200万人から2054年には3億8,300万人に増加すると推定しました。さらに、世界の60歳以上の人口は倍増し、2050年には21億人に達すると予想されています。このように、高齢化人口の増加が先天代謝異常用医療食品市場の成長を牽引しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の先天代謝異常用医療食品 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の先天代謝異常用医療食品市場：成長率分析
• 世界の先天代謝異常用医療食品市場の実績：規模と成長, 2019-2024
• 世界の先天代謝異常用医療食品市場の予測：規模と成長, 2024-2029, 2034F
• 世界の先天代謝異常用医療食品総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の先天代謝異常用医療食品市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• アミノ酸
• グリタクチンGMP配合アミノ酸配合乳幼児用鉄分配合調製乳
• 低カルシウムまたはビタミンDを含まない乳幼児用鉄分配合調製乳
• 低タンパク質食品
• その他の製品
• 世界の先天代謝異常用医療食品市場：疾患別、実績と予測, 2019-2024, 2024-2029F, 2034F
• フェニルケトン尿症（PKU）
• メープルシロップ尿症（MSUD）
• ホモシスチン尿症
• メチルマロン酸血症
• 有機酸尿症
• プロピオン酸血症
• イソ吉草酸血症
• ロイシン代謝障害
• グルタル酸血症I型腎疾患
• その他の疾患
• 世界の先天代謝異常用医療食品市場：年齢層別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 乳児
• 離乳
• 思春期
• 大人
• 世界の先天代謝異常用医療食品市場：形態別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 粉
• 液体
• ジェル
• その他の形態
• 世界の先天代謝異常用医療食品市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小売薬局
• 病院薬局
• ドラッグストア
• オンライン薬局
• その他の流通チャネル
• 世界の先天代謝異常用医療食品市場、タイプ別サブセグメンテーション：アミノ酸、実績と予測, 2019-2024, 2024-2029F, 2034F
• 粉末アミノ酸配合
• 液体アミノ酸配合
• 世界の先天代謝異常用医療食品市場、タイプ別サブセグメンテーション：グリタクチンGMP配合アミノ酸配合乳幼児用鉄分配合調製乳、実績と予測, 2019-2024, 2024-2029F, 2034F
• グリタクチンパウダー
• グリタクチンのすぐに使える製剤
• 特定の条件に対するGMP処方
• 標準GMPアミノ酸修飾配合
• 世界の先天代謝異常用医療食品市場、タイプ別サブセグメンテーション：低カルシウムまたはビタミンDを含まない乳幼児用鉄分配合調製乳、実績と予測, 2019-2024, 2024-2029F, 2034F
• 低カルシウムまたはビタミンDを含まない液体栄養剤
• 低カルシウムまたはビタミンDを含まない粉末調製乳
• 世界の先天代謝異常用医療食品市場、タイプ別サブセグメンテーション：低タンパク質食品、実績と予測, 2019-2024, 2024-2029F, 2034F
• 低タンパク質パスタと麺類
• 低タンパク質スナック
• 低タンパク質ベーカリー製品
• 世界の先天代謝異常用医療食品市場、タイプ別サブセグメンテーション：その他の製品、実績と予測, 2019-2024, 2024-2029F, 2034F
• 専門サプリメント
• 栄養バー
• RTU治療食品

第7章 地域別・国別分析

• 世界の先天代謝異常用医療食品市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の先天代謝異常用医療食品市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 先天代謝異常用医療食品市場：競合情勢
• 先天代謝異常用医療食品市場：企業プロファイル
  • Nestle Health Science Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Danone Nutricia Overview, Products and Services, Strategy and Financial Analysis
  • Vitaflo International Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • BioMarin Pharmaceutical Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Cambrooke Therapeutics Inc.
• Galen US Inc.
• Nutricia North America
• Solace Nutrition LLC
• Nutricia Advanced Medical Nutrition
• Ajinomoto Cambrooke Inc.
• Primus Pharmaceuticals Inc.
• Applied Nutrition Corp.
• Metagenics Inc.
• PKU Perspectives Inc.
• Medtrition Inc.
• Nutricia Pty Ltd.
• Arla Foods Ingredients Group P/S
• Aegle Nutrition LLC
• Homestat Farm Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 先天代謝異常用医療食品市場2029：新たな機会を提供する国
• 先天代謝異常用医療食品市場2029：新たな機会を提供するセグメント
• 先天代謝異常用医療食品市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Medical foods for inborn errors of metabolism encompass dietary supplements tailored for individuals with genetic conditions impacting metabolic functions. These products address specific nutritional needs in the management of these conditions. Key categories include amino acid formulations, glytactin with GMP amino acid-modified infant formula with iron, low-calcium/vitamin D-free infant formula with iron, low protein foods, and more. Amino acids, essential components found in living cells, are employed in medical foods for inborn errors of metabolism to offer alternative sources of crucial amino acids, bypassing those the individual's body struggles to metabolize effectively.

These medical foods cater to a range of disorders, including phenylketonuria (PKU), maple syrup urine disease (MSUD), homocystinuria, methylmalonic acidemia, organic acidurias, propionic acidemia, isovaleric acidemia, disorders of leucine metabolism, glutaric acidemia type I, renal disease, and others. Tailored for various age groups such as infants, weaning, adolescents, and adults, these products are available in diverse forms such as powders, liquids, gels, and more. Distribution channels include retail pharmacies, hospital pharmacies, drug stores, online pharmacies, and other relevant outlets.

The medical foods for inborn errors of metabolism market research report is one of a series of new reports from The Business Research Company that provides medical foods for inborn errors of metabolism market statistics, including medical foods for inborn errors of metabolism industry global market size, regional shares, competitors with a medical foods for inborn errors of metabolism market share, detailed medical foods for inborn errors of metabolism market segments, medical foods for inborn errors of metabolism market trends and opportunities, and any further data you may need to thrive in the medical foods for inborn errors of metabolism industry. This medical foods for inborn errors of metabolism market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical foods for inborn errors of metabolism market size has grown rapidly in recent years. It will grow from $3.08 billion in 2024 to $3.47 billion in 2025 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to global health initiatives, increased recognition of nutritional therapies, precision medicine approaches, increasing incidence of metabolic disorders, and personalized digital nutrition platforms

The medical foods for inborn errors of metabolism market size is expected to see rapid growth in the next few years. It will grow to $5.43 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to telehealth integration, rising demand for clean-label products, expanded newborn screening programs, patient-centric care models, and plant-based and sustainable formulations. Major trends in the forecast period include technological advancements in genetic testing, advancements in food processing technologies, innovations in ingredient technology, and technological advancements in food formulation.

The increasing prevalence of genetic (inherited) disorders is anticipated to drive the growth of the medical foods market for inborn errors of metabolism in the coming years. Genetic disorders are conditions caused entirely or partially by variations in the standard DNA sequence. Medical foods play a crucial role in providing specialized nutrition for infants with metabolic disorders, tailored to meet their unique metabolic needs, thus helping to prevent nutritional deficiencies and support their growth and overall well-being. For example, in May 2024, the Centers for Disease Control and Prevention (CDC), a U.S.-based public health agency, reported that sickle cell disease (SCD) affects approximately 100,000 individuals in the United States, with over 90% of those impacted being non-Hispanic Black or African American, and an estimated 3%-9% being Hispanic or Latino. Consequently, the rise in genetic disorders is fueling the growth of the medical foods market for inborn errors of metabolism.

The increasing aging population is projected to boost the growth of the medical food market for inborn errors of metabolism in the coming years. An aging population refers to a demographic trend marked by a growing percentage of elderly individuals within a society. Medical food for inborn errors of metabolism caters to the nutritional needs and metabolic challenges faced by older adults with specific disorders. For instance, in January 2022, the Congressional Budget Office, a U.S.-based federal agency, estimated that the population eligible for Social Security payroll taxes and benefits would rise from 342 million in 2024 to 383 million by 2054. Additionally, the global population of individuals aged 60 and older is expected to double, reaching 2.1 billion by 2050. Thus, the rising aging population is driving the growth of the medical food market for inborn errors of metabolism.

Product innovation has become a prominent trend in the medical food market for inborn errors of metabolism. Leading companies in this sector are focusing on developing cutting-edge products to enhance their market presence. For instance, in October 2023, Galen Limited, a UK-based pharmaceutical firm, introduced PKU Easy Microtabs Plus as part of its Medical Nutrition line. This product is designed to aid in the dietary management of Phenylketonuria (PKU), a metabolic disorder. PKU Easy Microtabs Plus provides patients with a more convenient and precise way to control their phenylalanine levels through small, easy-to-swallow microtabs. This innovative formulation aims to improve the quality of life for individuals with PKU by facilitating better dose customization and ease of use.

Major companies in the medical food for inborn errors of metabolism market are also directing their efforts towards developing innovative metabolic products, such as solid-dose protein substitutes, to address dietary management needs and gain a competitive edge. A notable example is Galen Medical Nutrition, an Ireland-based company, which, in October 2022, introduced TYR EASY Tablets into the UK market. These unique solid-dose protein substitutes for tyrosinemia are provided in tablet form and cater to patients over the age of 8, offering more options for protein substitutes tailored to their daily requirements.

In July 2023, Pentec Health, a US-based provider of specialty infusion services and medical foods, acquired ZOIA Pharma for an undisclosed amount. Through this acquisition, Pentec Health aims to enhance its product portfolio by incorporating the PKU GOLIKE family of medical food products, specifically designed for the dietary management of phenylketonuria (PKU). The PKU GOLIKE range offers patients innovative options to effectively manage their protein intake. ZOIA Pharma is a US-based organization dedicated to developing medical food specifically for inborn errors of metabolism.

Major companies operating in the medical foods for inborn errors of metabolism market include Nestle Health Science, Abbott Laboratories, Danone Nutricia, Vitaflo International Ltd., BioMarin Pharmaceutical Inc., Cambrooke Therapeutics Inc., Galen US Inc., Nutricia North America, Solace Nutrition LLC, Nutricia Advanced Medical Nutrition, Ajinomoto Cambrooke Inc., Primus Pharmaceuticals Inc., Applied Nutrition Corp., Metagenics Inc., PKU Perspectives Inc., Medtrition Inc., Nutricia Pty Ltd., Arla Foods Ingredients Group P/S, Aegle Nutrition LLC, Homestat Farm Ltd., Ketovie Nutrition, Formulaid, International Nutrition Inc., Phesgo Medical Foods, Immedica Pharma AB, Meiji Holdings Co. Ltd.

North America was the dominant region in the medical foods for inborn errors of metabolism market in 2024. The regions covered in the medical foods for inborn errors of metabolism market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical foods for inborn errors of metabolism market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical food for inborn errors of the metabolism market consists of sales of galactose-free formulas, modified starches and carbohydrate supplements, and Vitamin pyridoxine (B6) supplements. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Medical Foods For Inborn Errors Of Metabolism Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medical foods for inborn errors of metabolism market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for medical foods for inborn errors of metabolism ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The medical foods for inborn errors of metabolism market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Amino Acid; Glytactin With GMP Amino Acid-Modified Infant Formula with Iron; Low-Calcium Or Vitamin D-Free Infant Formula With Iron; Low Protein Food; Other Products
• 2) By Diseases: Phenylketonuria (PKU); Maple Syrup Urine Disease (MSUD); Homocystinuria; Methylmalonic Acidemia; Organic Acidurias; Propionic Acidemia; Isovaleric Acidemia; Disorders Of Leucine Metabolism; Glutaric Acidemia Type I Renal Disease; Other Diseases
• 3) By Age Group: Infants; Weaning; Adolescent; Adults
• 4) By Forms: Powder; Liquids; Gels; Other Forms
• 5) By Distribution Channel: Retail Pharmacies; Hospital Pharmacies; Drugs Stores; Online Pharmacies; Other Distribution Channels
• Subsegments:
• 1) By Amino Acid: Powdered Amino Acid Formulas; Liquid Amino Acid Formulas
• 2) By Glytactin With GMP Amino Acid-Modified Infant Formula With Iron: Glytactin Powder; Glytactin Ready-To-Use Formulations; GMP Formulas For Specific Conditions; Standard GMP Amino Acid-Modified Formulas
• 3) By Low-Calcium Or Vitamin D-Free Infant Formula With Iron: Liquid Low-Calcium Or Vitamin D-Free Formulas; Powdered Low-Calcium Or Vitamin D-Free Formulas
• 4) By Low Protein Food: Low Protein Pasta And Noodles; Low Protein Snacks; Low Protein Bakery Products
• 5) By Other Products: Specialized Supplements; Nutritional Bars; Ready-To-Use Therapeutic Foods
• Companies Mentioned: Nestle Health Science; Abbott Laboratories; Danone Nutricia; Vitaflo International Ltd.; BioMarin Pharmaceutical Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Medical Foods For Inborn Errors Of Metabolism Market Characteristics

3. Medical Foods For Inborn Errors Of Metabolism Market Trends And Strategies

4. Medical Foods For Inborn Errors Of Metabolism Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Medical Foods For Inborn Errors Of Metabolism Growth Analysis And Strategic Analysis Framework

• 5.1. Global Medical Foods For Inborn Errors Of Metabolism PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Medical Foods For Inborn Errors Of Metabolism Market Growth Rate Analysis
• 5.4. Global Medical Foods For Inborn Errors Of Metabolism Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Medical Foods For Inborn Errors Of Metabolism Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Medical Foods For Inborn Errors Of Metabolism Total Addressable Market (TAM)

6. Medical Foods For Inborn Errors Of Metabolism Market Segmentation

• 6.1. Global Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Amino Acid
• Glytactin With GMP Amino Acid-Modified Infant Formula with Iron
• Low-Calcium Or Vitamin D-Free Infant Formula With Iron
• Low Protein Food
• Other Products
• 6.2. Global Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Phenylketonuria (PKU)
• Maple Syrup Urine Disease (MSUD)
• Homocystinuria
• Methylmalonic Acidemia
• Organic Acidurias
• Propionic Acidemia
• Isovaleric Acidemia
• Disorders Of Leucine Metabolism
• Glutaric Acidemia Type I Renal Disease
• Other Diseases
• 6.3. Global Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Infants
• Weaning
• Adolescent
• Adults
• 6.4. Global Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Forms, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Powder
• Liquids
• Gels
• Other Forms
• 6.5. Global Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Retail Pharmacies
• Hospital Pharmacies
• Drugs Stores
• Online Pharmacies
• Other Distribution Channels
• 6.6. Global Medical Foods For Inborn Errors Of Metabolism Market, Sub-Segmentation Of Amino Acid, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Powdered Amino Acid Formulas
• Liquid Amino Acid Formulas
• 6.7. Global Medical Foods For Inborn Errors Of Metabolism Market, Sub-Segmentation Of Glytactin With GMP Amino Acid-Modified Infant Formula With Iron, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Glytactin Powder
• Glytactin Ready-To-Use Formulations
• GMP Formulas For Specific Conditions
• Standard GMP Amino Acid-Modified Formulas
• 6.8. Global Medical Foods For Inborn Errors Of Metabolism Market, Sub-Segmentation Of Low-Calcium Or Vitamin D-Free Infant Formula With Iron, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liquid Low-Calcium Or Vitamin D-Free Formulas
• Powdered Low-Calcium Or Vitamin D-Free Formulas
• 6.9. Global Medical Foods For Inborn Errors Of Metabolism Market, Sub-Segmentation Of Low Protein Food, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Low Protein Pasta And Noodles
• Low Protein Snacks
• Low Protein Bakery Products
• 6.10. Global Medical Foods For Inborn Errors Of Metabolism Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Specialized Supplements
• Nutritional Bars
• Ready-To-Use Therapeutic Foods

7. Medical Foods For Inborn Errors Of Metabolism Market Regional And Country Analysis

• 7.1. Global Medical Foods For Inborn Errors Of Metabolism Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Medical Foods For Inborn Errors Of Metabolism Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Medical Foods For Inborn Errors Of Metabolism Market

• 8.1. Asia-Pacific Medical Foods For Inborn Errors Of Metabolism Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Medical Foods For Inborn Errors Of Metabolism Market

• 9.1. China Medical Foods For Inborn Errors Of Metabolism Market Overview
• 9.2. China Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Medical Foods For Inborn Errors Of Metabolism Market

• 10.1. India Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Medical Foods For Inborn Errors Of Metabolism Market

• 11.1. Japan Medical Foods For Inborn Errors Of Metabolism Market Overview
• 11.2. Japan Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Medical Foods For Inborn Errors Of Metabolism Market

• 12.1. Australia Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Medical Foods For Inborn Errors Of Metabolism Market

• 13.1. Indonesia Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Medical Foods For Inborn Errors Of Metabolism Market

• 14.1. South Korea Medical Foods For Inborn Errors Of Metabolism Market Overview
• 14.2. South Korea Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Medical Foods For Inborn Errors Of Metabolism Market

• 15.1. Western Europe Medical Foods For Inborn Errors Of Metabolism Market Overview
• 15.2. Western Europe Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Medical Foods For Inborn Errors Of Metabolism Market

• 16.1. UK Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Medical Foods For Inborn Errors Of Metabolism Market

• 17.1. Germany Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Medical Foods For Inborn Errors Of Metabolism Market

• 18.1. France Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Medical Foods For Inborn Errors Of Metabolism Market

• 19.1. Italy Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Medical Foods For Inborn Errors Of Metabolism Market

• 20.1. Spain Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Medical Foods For Inborn Errors Of Metabolism Market

• 21.1. Eastern Europe Medical Foods For Inborn Errors Of Metabolism Market Overview
• 21.2. Eastern Europe Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Medical Foods For Inborn Errors Of Metabolism Market

• 22.1. Russia Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Medical Foods For Inborn Errors Of Metabolism Market

• 23.1. North America Medical Foods For Inborn Errors Of Metabolism Market Overview
• 23.2. North America Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Medical Foods For Inborn Errors Of Metabolism Market

• 24.1. USA Medical Foods For Inborn Errors Of Metabolism Market Overview
• 24.2. USA Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Medical Foods For Inborn Errors Of Metabolism Market

• 25.1. Canada Medical Foods For Inborn Errors Of Metabolism Market Overview
• 25.2. Canada Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Medical Foods For Inborn Errors Of Metabolism Market

• 26.1. South America Medical Foods For Inborn Errors Of Metabolism Market Overview
• 26.2. South America Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Medical Foods For Inborn Errors Of Metabolism Market

• 27.1. Brazil Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Medical Foods For Inborn Errors Of Metabolism Market

• 28.1. Middle East Medical Foods For Inborn Errors Of Metabolism Market Overview
• 28.2. Middle East Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Medical Foods For Inborn Errors Of Metabolism Market

• 29.1. Africa Medical Foods For Inborn Errors Of Metabolism Market Overview
• 29.2. Africa Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Diseases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Medical Foods For Inborn Errors Of Metabolism Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Medical Foods For Inborn Errors Of Metabolism Market Competitive Landscape And Company Profiles

• 30.1. Medical Foods For Inborn Errors Of Metabolism Market Competitive Landscape
• 30.2. Medical Foods For Inborn Errors Of Metabolism Market Company Profiles
  • 30.2.1. Nestle Health Science Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Danone Nutricia Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Vitaflo International Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. BioMarin Pharmaceutical Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Medical Foods For Inborn Errors Of Metabolism Market Other Major And Innovative Companies

• 31.1. Cambrooke Therapeutics Inc.
• 31.2. Galen US Inc.
• 31.3. Nutricia North America
• 31.4. Solace Nutrition LLC
• 31.5. Nutricia Advanced Medical Nutrition
• 31.6. Ajinomoto Cambrooke Inc.
• 31.7. Primus Pharmaceuticals Inc.
• 31.8. Applied Nutrition Corp.
• 31.9. Metagenics Inc.
• 31.10. PKU Perspectives Inc.
• 31.11. Medtrition Inc.
• 31.12. Nutricia Pty Ltd.
• 31.13. Arla Foods Ingredients Group P/S
• 31.14. Aegle Nutrition LLC
• 31.15. Homestat Farm Ltd.

32. Global Medical Foods For Inborn Errors Of Metabolism Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Medical Foods For Inborn Errors Of Metabolism Market

34. Recent Developments In The Medical Foods For Inborn Errors Of Metabolism Market

35. Medical Foods For Inborn Errors Of Metabolism Market High Potential Countries, Segments and Strategies

• 35.1 Medical Foods For Inborn Errors Of Metabolism Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Medical Foods For Inborn Errors Of Metabolism Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Medical Foods For Inborn Errors Of Metabolism Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer